Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1 vs 2 RBC Units Transfusion Strategy in Hematology
NCT02461264Phase 3Unknown
- Sponsor
- CHU Caen Normandie
- Start
- Jan 2016
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of red blood cells in anemia (2 arms), sponsored by CHU Caen Normandie. Primary endpoint: Number of severe complications (grade 3 or more). Status: unknown.
02
Drugs
red blood cells
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02461264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461264.